Headshot of Mahmoud Maina.

Mahmoud Bukar Maina

Junior group leader
Biomedical Science Research and Training Centre, Yobe State University and the University of Sussex

Mahmoud Bukar Maina holds dual roles as junior group leader at the Biomedical Science Research and Training Centre at Yobe State University in Nigeria and in the neuroscience department at the University of Sussex in the United Kingdom. His team’s research focuses on generating induced pluripotent stem cells from Indigenous African people for open-access biobanking and investigating the molecular mechanisms of tauopathies in the context of African genetic backgrounds.

In his previous work, Maina identified a critical function of tau in the nucleolus, which sparked his ongoing research on the potential role of ancestry-driven rDNA variations in nucleolar dysfunction in tauopathies. With more than a decade of experience in initiatives to strengthen African science, he sits on multiple local and international committees and serves as a science adviser for the Yobe State Government, where he advises various institutions and funders both within and beyond Africa. He has received several recognitions, including the ALBA-FKNE Diversity Prize for the promotion of basic neuroscience and the Royal Society’s Global Talent visa.

From this contributor

Explore more from The Transmitter

Research image of lesion network mapping.

‘Overdue’ debate unfurls over neuroimaging method

After a January paper questioned the validity of an approach called lesion network mapping, its users are pressure testing their results.

By Angie Voyles Askham
17 April 2026 | 8 min read
Research image of zebrafish brain activity.

Nearly 400 compounds affect behaviors tied to autism-linked genes in zebrafish

Estropipate, paclitaxel and levocarnitine altered behaviors tied to SCN2A and DYRK1A variants specifically, a new open-source platform revealed.

By Charles Q. Choi
16 April 2026 | 4 min read
NINDS building.

What neuroscientists want from a new NINDS director

The search is underway for the next director of the U.S. National Institute of Neurological Disorders and Stroke, who will face a range of challenges, neuroscientists say, but will also have an “immense opportunity to do good things.”

By Helena Kudiabor
15 April 2026 | 4 min read